Caribou Biosciences Inc (CRBU)
1.98
+0.04
(+2.06%)
USD |
NASDAQ |
Sep 27, 16:00
1.97
-0.01
(-0.51%)
After-Hours: 20:00
Caribou Biosciences Total Assets (Quarterly): 372.94M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 372.94M |
March 31, 2024 | 406.82M |
December 31, 2023 | 432.21M |
September 30, 2023 | 457.52M |
June 30, 2023 | 349.65M |
March 31, 2023 | 347.46M |
December 31, 2022 | 373.76M |
September 30, 2022 | 398.82M |
Date | Value |
---|---|
June 30, 2022 | 421.37M |
March 31, 2022 | 446.00M |
December 31, 2021 | 442.36M |
September 30, 2021 | 461.96M |
June 30, 2021 | 158.40M |
March 31, 2021 | 167.96M |
December 31, 2020 | 36.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
36.05M
Minimum
Dec 2020
461.96M
Maximum
Sep 2021
351.55M
Average
398.82M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
Celldex Therapeutics Inc | 845.59M |
Vir Biotechnology Inc | 1.670B |
Beam Therapeutics Inc | 1.261B |
Relay Therapeutics Inc | 772.55M |
CEL-SCI Corp | 24.07M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 62.47M |
Shareholders Equity (Quarterly) | 310.46M |
Current Ratio | 8.754 |